261 related articles for article (PubMed ID: 22493545)
1. Enhancement of CTLs induced by DCs loaded with ubiquitinated hepatitis B virus core antigen.
Chen JH; Yu YS; Chen XH; Liu HH; Zang GQ; Tang ZH
World J Gastroenterol; 2012 Mar; 18(12):1319-27. PubMed ID: 22493545
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cell-based vaccination with lentiviral vectors encoding ubiquitinated hepatitis B core antigen enhances hepatitis B virus-specific immune responses in vivo.
Dai S; Zhuo M; Song L; Chen X; Yu Y; Tang Z; Zang G
Acta Biochim Biophys Sin (Shanghai); 2015 Nov; 47(11):870-9. PubMed ID: 26373843
[TBL] [Abstract][Full Text] [Related]
3. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice.
Dai S; Zhuo M; Song L; Chen X; Yu Y; Zang G; Tang Z
Immunobiology; 2016 Jul; 221(7):813-21. PubMed ID: 26874581
[TBL] [Abstract][Full Text] [Related]
4. Generation of cytotoxic T cell against HBcAg using retrovirally transduced dendritic cells.
Ding CL; Yao K; Zhang TT; Zhou F; Xu L; Xu JY
World J Gastroenterol; 2003 Jul; 9(7):1512-5. PubMed ID: 12854153
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-modified hepatitis B virus core antigen effectively facilitates antigen presentation and enhances cytotoxic T lymphocyte activity via the cytoplasmic transduction peptide in vitro.
Song L; Zhuo M; Tang Y; Chen X; Yu Y; Tang Z; Zang G
Mol Med Rep; 2015 Jul; 12(1):289-96. PubMed ID: 25684256
[TBL] [Abstract][Full Text] [Related]
6. [HBcAg-specific CTL response induced by PTD-HBcAg fusion protein to inhibit HBV replication in vitro].
Chen XH; Pan QC; Yu YS; Tang ZH; Zang GQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):289-92. PubMed ID: 19351491
[TBL] [Abstract][Full Text] [Related]
7. An Engineered DC-Targeting Lentivector Induces Robust T Cell Responses and Inhibits HBV Replication in HBV Transgenic Mice via Upregulating T Cell Autophagy.
Ma S; Chen X; Tan Q; Dai S; Li D; Wu S; Yu Y; Zang G; Tang Z
Cell Physiol Biochem; 2018; 48(3):1041-1059. PubMed ID: 30041239
[TBL] [Abstract][Full Text] [Related]
8. Immunization with lentiviral vector‑modified dendritic cells encoding ubiquitinated hepatitis B core antigen promotes Th1 differentiation and antiviral immunity by enhancing p38 MAPK and JNK activation in HBV transgenic mice.
Dai S; Chen X; Yu Y; Zang G; Tang Z
Mol Med Rep; 2018 Nov; 18(5):4691-4699. PubMed ID: 30221736
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of lentivirus-mediated interleukin -12 gene modified dendritic cells in human lung cancer in vitro.
Ahmed Ali HA; Di J; Mei W; Zhang YC; Li Y; Du ZW; Zhang GZ
Asian Pac J Cancer Prev; 2014; 15(2):611-6. PubMed ID: 24568466
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of cytotoxic T lymphocyte activity by dendritic cells loaded with Tat-protein transduction domain-fused hepatitis B virus core antigen.
Chen X; Yu Y; Pan Q; Tang Z; Han J; Zang G
Acta Biochim Biophys Sin (Shanghai); 2008 Dec; 40(12):996-1004. PubMed ID: 19089297
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances HBV-specific humoral and CTL immune responses in vivo.
Song L; Zhuo M; Tang Y; Chen X; Tang Z; Zang G
Int Immunopharmacol; 2014 Nov; 23(1):1-7. PubMed ID: 25135878
[TBL] [Abstract][Full Text] [Related]
12. Exosomes from Ub‑HBcAg‑overexpressing dendritic cells induce T‑lymphocyte differentiation and enhance cytotoxic T‑lymphocyte activity.
Yang Y; Liu K; Zhou W; Dai S
Exp Ther Med; 2023 Apr; 25(4):167. PubMed ID: 36936705
[TBL] [Abstract][Full Text] [Related]
13. [Retroviral-mediated transfection of hepatitis B virus core gene into bone marrow-derived dendritic cells].
Ding CL; Yao K; Zhang TT; Peng GY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 May; 19(3):299-301. PubMed ID: 15155100
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus Vector Harboring the HBcAg and Tripeptidyl Peptidase II Genes Induces Potent Cellular Immune Responses In Vivo.
Tan Q; Ma S; Hu J; Chen X; Yu Y; Tang Z; Zang G
Cell Physiol Biochem; 2017; 41(2):423-438. PubMed ID: 28214886
[TBL] [Abstract][Full Text] [Related]
15. Immunostimulatory activities of dendritic cells loaded with adenovirus vector carrying HBcAg/HBsAg.
Jia H; Li C; Zhang Y; Yu L; Xiang D; Liu J; Chen F; Han X
Int J Clin Exp Med; 2015; 8(3):3456-64. PubMed ID: 26064236
[TBL] [Abstract][Full Text] [Related]
16. HBcAg-pulsed dendritic cell vaccine induces Th1 polarization and production of hepatitis B virus-specific cytotoxic T lymphocytes.
Chen W; Shi M; Shi F; Mao Y; Tang Z; Zhang B; Zhang H; Chen L; Chen L; Xin S; Wang FS
Hepatol Res; 2009 Apr; 39(4):355-65. PubMed ID: 19889049
[TBL] [Abstract][Full Text] [Related]
17. The modification of Tapasin enhances cytotoxic T lymphocyte activity of intracellularly delivered CTL epitopes via cytoplasmic transduction peptide.
Chen X; Liu H; Tang Z; Yu Y; Zang G
Acta Biochim Biophys Sin (Shanghai); 2013 Mar; 45(3):203-12. PubMed ID: 23299079
[TBL] [Abstract][Full Text] [Related]
18. Tumor antigen-pulsed CD8α(+) dendritic cells induce T cell-mediated graft-versus-tumor effect in vitro.
Na N; Chen K; Zhang J; He S; Fu Q; Zhu B; Cao K; Xu L
J Huazhong Univ Sci Technolog Med Sci; 2011 Dec; 31(6):728-734. PubMed ID: 22173490
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells transfected with lentiviral vector-encoding hTERT peptide augment antitumor T cell response in vitro.
Cui J; Cui L; Liu Q; Sun Q
Mol Med Rep; 2012 Jan; 5(1):103-7. PubMed ID: 21971748
[TBL] [Abstract][Full Text] [Related]
20. Enhanced induction of anti-tumor CTLs in vitro by a lentivirus-transduced dendritic cell vaccine expressing secondary lymphoid tissue chemokine and mucin 1.
Wang B; Zhu Y; Zhang JJ; Chen Z; Liang WB; Xu ZK
Asian Pac J Cancer Prev; 2011; 12(11):2811-7. PubMed ID: 22393946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
